BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 21474609)

  • 1. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
    Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
    J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
    Vediyappan G; Rossignol T; d'Enfert C
    Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of fluconazole resistance-associated genes in biofilm from 23 clinical isolates of Candida albicans.
    Shi C; Liu J; Li W; Zhao Y; Meng L; Xiang M
    Braz J Microbiol; 2019 Jan; 50(1):157-163. PubMed ID: 30617866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
    Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of agglutinin-like sequence protein 3 (Als3) in the structure and antifungal resistance of Candida albicans biofilms.
    Liu C; Xu C; Du Y; Liu J; Ning Y
    FEMS Microbiol Lett; 2021 Jul; 368(14):. PubMed ID: 34232317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
    Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
    Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for cell density in antifungal drug resistance in Candida albicans biofilms.
    Perumal P; Mekala S; Chaffin WL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
    Chen S; Xia J; Li C; Zuo L; Wei X
    BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.
    Yu LH; Wei X; Ma M; Chen XJ; Xu SB
    Antimicrob Agents Chemother; 2012 Feb; 56(2):770-5. PubMed ID: 22106223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
    Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
    Gołąbek K; Strzelczyk JK; Owczarek A; Cuber P; Ślemp-Migiel A; Wiczkowski A
    Acta Biochim Pol; 2015; 62(2):247-51. PubMed ID: 25901298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Biofilm Formation by
    Lee JH; Kim YG; Khadke SK; Yamano A; Watanabe A; Lee J
    ACS Infect Dis; 2019 Jul; 5(7):1177-1187. PubMed ID: 31055910
    [No Abstract]   [Full Text] [Related]  

  • 14. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo.
    Bink A; Govaert G; Vandenbosch D; Kuchariková S; Coenye T; Nelis H; Van Dijck P; Cammue BPA; Thevissen K
    J Med Microbiol; 2012 Jun; 61(Pt 6):813-819. PubMed ID: 22422573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
    Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
    mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
    De Brucker K; De Cremer K; Cammue BP; Thevissen K
    Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives.
    Shafreen RM; Muthamil S; Pandian SK
    Appl Microbiol Biotechnol; 2014 Aug; 98(15):6775-85. PubMed ID: 24723295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of fluconazole and doxycycline against Candida albicans biofilms resulting from calcium fluctuation and downregulation of fluconazole-inducible efflux pump gene overexpression.
    Gao Y; Li H; Liu S; Zhang X; Sun S
    J Med Microbiol; 2014 Jul; 63(Pt 7):956-961. PubMed ID: 24809386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W; Zhang H; Li C; Li G; Liu X; Wei J
    BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.